FTC sues important pharmacy reward administrators over insulin prices The company brought action against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of daily life-saving insulin medication. Before this summertime, the organization held prolonged negotiations with Steward around tips on https://label-the-figure-with-the70246.tkzblog.com/30549765/the-2-minute-rule-for-healthcare-news